Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-17 4:23 pm Purchase | 2026-11-10 | 13G | GENEDX HLDGS CORP WGS | Deep Track Capital, LP | 1,800,000 6.010% | 1,800,000![]() (New Position) | Filing History |
| 2026-11-16 08:49 am Sale | 2026-09-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Deep Track Capital, LP | 6,663,821 6.580% | -1,377,073![]() (-17.13%) | Filing History |
| 2026-11-16 08:48 am Purchase | 2026-09-30 | 13G | VERA THERAPEUTICS INC VERA | Deep Track Capital, LP | 7,000,000 9.710% | 3,078,638![]() (+78.51%) | Filing History |
| 2026-11-16 08:47 am Unchanged | 2026-09-30 | 13G | SHATTUCK LABS INC STTK | Deep Track Capital, LP | 5,000,033 4.920% | 0 (Unchanged) | Filing History |
| 2026-11-16 08:46 am Sale | 2026-09-30 | 13G | OBSIDIAN THERAPEUTICS INC OBX | Deep Track Capital, LP | 2,120,050 3.430% | -1,195,555![]() (-36.06%) | Filing History |
| 2026-11-16 08:44 am Sale | 2026-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 6,000,000 5.490% | -1,736,455![]() (-22.45%) | Filing History |
| 2026-11-16 08:43 am Purchase | 2026-09-30 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | Deep Track Capital, LP | 15,000,000 7.180% | 2,664,654![]() (+21.60%) | Filing History |
| 2026-11-13 4:06 pm Purchase | 2026-11-06 | 13G | INMED PHARMACEUTICALS INC INM | Deep Track Capital, LP | 2,977,478 5.640% | 2,977,478![]() (New Position) | Filing History |
| 2026-10-23 4:01 pm Purchase | 2026-10-16 | 13G | TCX CALIBUR INC - TCXB | Deep Track Capital, LP | 990,000 9.900% | 990,000![]() (New Position) | Filing History |
| 2026-10-23 4:01 pm Purchase | 2026-10-16 | 13G | ALECTOR INC ALEC | Deep Track Capital, LP | 12,772,152 8.610% | 12,772,152![]() (New Position) | Filing History |
| 2026-10-21 4:15 pm Purchase | 2026-10-14 | 13G | Frazier Life Sciences Acquisition Corp. II FLSC | Deep Track Capital, LP | 700,000 8.970% | 700,000![]() (New Position) | Filing History |
| 2026-09-02 4:01 pm Purchase | 2026-08-26 | 13G | JATT III ACQUISITION CORP USD JTTT | Deep Track Capital, LP | 450,000 5.830% | 450,000![]() (New Position) | Filing History |
| 2026-08-14 08:36 am Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 7,736,455 7.450% | 1,391,211![]() (+21.93%) | Filing History |
| 2026-08-14 08:34 am Purchase | 2026-06-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Deep Track Capital, LP | 8,040,894 8.330% | 5,673,899![]() (+239.71%) | Filing History |
| 2026-08-14 08:32 am Sale | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital, LP | 3,592,740 3.250% | -1,824,920![]() (-33.68%) | Filing History |
| 2026-08-14 08:32 am Sale | 2026-06-30 | 13G | PERSONALIS INC PSNL | Deep Track Capital, LP | 4,000,000 3.820% | -1,760,627![]() (-30.56%) | Filing History |
| 2026-08-14 08:28 am Purchase | 2026-06-30 | 13G | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | Deep Track Capital, LP | 7,999,025 9.740% | 3,388,954![]() (+73.51%) | Filing History |
| 2026-08-14 08:27 am Sale | 2026-06-30 | 13G | MBX BIOSCIENCES INC MBX | Deep Track Capital, LP | 1,732,569 3.640% | -456,023![]() (-20.84%) | Filing History |
| 2026-08-14 08:27 am Sale | 2026-06-30 | 13G | IMMUNOVANT INC IMVT | Deep Track Capital, LP | 9,341,151 4.550% | -158,849![]() (-1.67%) | Filing History |
| 2026-08-14 08:26 am Sale | 2026-06-30 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Deep Track Capital, LP | 1,444,167 4.970% | -512,700![]() (-26.20%) | Filing History |

